omeprazole has been researched along with metronidazole in 668 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 293 (43.86) | 18.2507 |
| 2000's | 297 (44.46) | 29.6817 |
| 2010's | 66 (9.88) | 24.3611 |
| 2020's | 12 (1.80) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bala, V; Chhonker, YS | 1 |
| Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR | 1 |
| Cortés-Benítez, F; Palacios-Espinosa, JF; Pérez-Villanueva, J; Rodríguez-Villar, K; Soria-Arteche, O; Yépez-Mulia, L | 1 |
| Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
| Cheng, A; Chung, SC; Hosking, SW; Leung, JW; Li, AK; Ling, TK; Yung, MY | 1 |
| Jaskiewicz, K; Lastovica, A; Le Roux, E; Louw, JA; Lucke, W; Marks, IN; Winter, T; Zak, J | 1 |
| Bell, GD; Bolton, G; Brooks, S; Burridge, SM; Gant, PW; Harrison, G; Powell, KU; Prosser, S; Purser, K; Spencer, G | 1 |
| Kosunen, TU; Rautelin, H; Renkonen, OV; Seppälä, K; Vaara, M | 1 |
| Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S | 1 |
| Andrews, P; Bae, H; Borody, TJ; Brandl, S; Fracchia, G; Shortis, NP | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Schepp, W | 1 |
| Contreras, L; Giglio, M; Hoffenberg, P; Ossa, P; Reyes, V; Weitz, JC | 1 |
| Folwaczny, C | 1 |
| al-Assi, MT; Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Armstrong, D; Blum, AL; Kreiss, C | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| Barbara, L; Holton, J; Menegatti, M; Vaira, D | 1 |
| de Boer, WA; Tytgat, GN | 2 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Cheng, AF; Chung, SC; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Johnson, CD; Ozmen, MM | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Minguzzi, M | 1 |
| Cederbrant, G; Kahlmeter, G; Kamme, C; Schalén, C | 1 |
| Hahm, JS; Kim, HJ; Park, KN | 1 |
| Atoyebi, W; Bell, GD; Bolton, GH; Bowden, AF; Brown, C; Burridge, SM; Jones, PH; Powell, KU | 1 |
| Brydon, WG; Eastwood, MA; Ferguson, A; Hudson, N; Palmer, KR | 1 |
| Klotz, O; Treiber, G | 1 |
| Cheng, AF; Chung, SC; Leung, VK; Li, AK; Li, MK; Ling, TK; Ng, EK; Sung, JJ; Yung, MY | 1 |
| Dunkin, K; Howard, AJ; Rubinstein, G | 1 |
| de Boer, WA; Driessen, WM | 2 |
| Rune, SJ | 1 |
| Goddard, A; Logan, R | 1 |
| Becker, T; Börsch, G; Labenz, J; Rühl, GH; Sollböhmer, M; Stolte, M; Tillenburg, B | 1 |
| Aase, S; Andersen, KJ; Mowinckel, P; Schrumpf, E; Vetvik, K | 1 |
| Borchard, F; Müller, W; Peters, U; tho Pesch, S | 1 |
| Archimandritis, A; Balatsos, V; Delis, V; Kastanas, K; Mentis, A; Scandalis, N | 1 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Ricken, D; Szymanski, C; Wegener, M | 1 |
| Bellas, C; Boixeda, D; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Harris, A; Misiewicz, JJ | 1 |
| de Boer, W; Driessen, W; Jansz, A; Tytgat, G | 1 |
| Cheng, AF; Chung, SC; Hosking, SW; Li, AK; Ling, TK; Sung, JJ; Yung, MY | 2 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Asaka, M; Horita, S; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Ohtaki, T | 1 |
| Goh, KL; Lo, YL; Parasakthi, N; Peh, SC; Tan, KK; Wong, NW | 1 |
| Karita, M; Morshed, MG; Okita, K; Ouchi, K | 1 |
| Axon, AT | 1 |
| Alvisi, C; Bianchi Porro, G; Boldorini, R; Fiocca, R; Lazzaroni, M; Luinetti, O; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Berman, D; George, J; Groisman, GM; Harpaz, N | 1 |
| Ammann, R; Bauer, S; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Börsch, G; Labenz, J | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Beattie, S; Collins, R; Hamilton, H; McCarthy, CJ; O'Morain, C | 1 |
| Bell, GD; Bolton, G; Bowden, AN; Brown, C; Burridge, SM; Gant, PW; Harrison, G; Powell, KU; Purser, K; Rameh, B | 1 |
| Andrews, P; Borody, TJ; Carroll, M; Ferch, N; Jankiewicz, E | 1 |
| Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 1 |
| Jaskiewicz, K; Louw, JA; Marks, IN | 1 |
| Baron, JH; Gummett, PA; Karim, QN; Logan, RP; Misiewicz, JJ; Walker, MM | 1 |
| Moolenaar, W; ten Bokkel Huinink, J; Thijs, JC; van Zwet, AA; Wolfhagen, MJ | 1 |
| Badve, S; Finlayson, C; Khulusi, S; Lloyd, R; Marrero, JM; Mendall, MA; Northfield, TC; Patel, P | 1 |
| Diehl, HG | 1 |
| Majka, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Axon, AT; Bate, CM; Bell, GD; Emmas, CE; Green, JR; Kerr, GD; Taylor, MD; Tildesley, G | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Battaglia, G; Cassaro, M; Dal Bó, N; Di Mario, F; Donisi, PM; Ferrana, M; Grassi, SA; Grasso, GA; Kusstatscher, S; Rugge, M; Salandin, S; Vianello, F | 1 |
| Davis, S | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Larsson, H; Sjöström, JE | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; García Plaza, A; García, M; Gisbert, JP; Martín de Argila, C | 1 |
| Alván, G; Blomgren, K | 1 |
| Artan, R; Gelen, T | 1 |
| Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Alkan, S; Cohen, P; Karcher, DS; Newman, MA | 1 |
| Barrett, DA; Cederberg, C; Goddard, AF; Idström, JP; Jessa, MJ; Shaw, PN; Spiller, RC | 1 |
| Lambert, JR | 1 |
| Ching, CK; Lai, CL; Lai, KC; Lam, SK; Leung, KP; Wong, BC; Yung, RW | 1 |
| Fox, JG; Hayward, A; Murphy, JC; Perkins, SE; Shen, Z; Yan, LL | 1 |
| Bell, JM; Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Polson, RJ; Rosengren, H | 1 |
| Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C | 1 |
| Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C | 1 |
| Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E | 1 |
| de Boer, WA; Driessen, WM; Jansz, AR; Tytgat, GN | 1 |
| Estrada, R; Garcia, F; Laine, L; Stein, C; Trujillo, M | 1 |
| Jaup, BH; Norrby, A | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ | 1 |
| Kapoor, H; Pollak, PT; Veldhuyzen van Zanten, SJ; Yeung, PK | 1 |
| Avsar, E; Gültekin, O; Kalayci, C; Kiziltas, S; Lawrence, R; Tözün, N; Ulusoy, NB | 1 |
| Griffiths, AE; Halliday, D; Jacyna, MR; Phull, PS | 1 |
| De Boer, WA; Driessen, WM; Tytgat, GN | 1 |
| Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Das, K; Goenka, MK; Kocbhar, R; Nijhawan, R; Vaiphei, K | 1 |
| Dammann, HG | 1 |
| Axon, AT; Bate, CM; Bell, GD; Martin, JL; Richardson, PD; Taylor, MD; Tildesley, G | 1 |
| De Boer, WA; Driessen, WM; Geuskens, LM; Lai, JY | 1 |
| Chiba, N | 1 |
| Herman, R; Konturek, JW; Konturek, SJ; Lorens, K; Tabor, S; Thor, P | 1 |
| Behler, EM; Chey, WD; Crause, I; Elta, GH; Scheiman, JM | 1 |
| Buiatti, E; Kato, I; Muñoz, N; Oliver, W; Vivas, J | 1 |
| Dankert, J; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
| Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
| Chua, RT; Lee, SD; Lin, HJ; Perng, CL; Tsay, SH; Wang, K | 1 |
| Pollak, PT | 1 |
| Kawano, S; Murakami, M; Saita, H; Tsuji, S | 1 |
| Ishino, Y; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yamamoto, H; Yoshida, Y | 1 |
| Gimeno, L; Gomollón, F; Marzo, J; Pérez-Caballero, MC; Valdepérez, J; Yus, C | 1 |
| Baron, JH; Gabe, SM; Harris, AW; Karim, QN; Langworthy, H; Misiewicz, JJ; Pryce, DI; Walker, MM | 1 |
| Brill, S; Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Goh, KL; Navaratnam, P; Peh, SC | 1 |
| Alvarez Baleriola, I; Boixeda, D; Gisbert, JP; Jiménez, I; Pajares, JM; Pérez García, JI; Redondo, C | 1 |
| Bock, H; Mares, A | 1 |
| Paar, D; Sauerbruch, T; Terjung, B | 1 |
| Kajiwara, M; Kawada, H; Kidaira, K; Kimura, K; Nishifuku, K; Sato, K; Sohara, H; Taniguchi, Y; Wang, XM | 1 |
| Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A | 1 |
| Dohil, R; Hassall, E; Israel, DM | 1 |
| Aubert, E; Berge, T; Breder, O; Farup, P; Flaaten, B; Haug, JB; Høie, O; Lerang, F; Moum, B; Søberg, T; Tolås, P | 1 |
| Adamek, RJ; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Tillenburg, B | 1 |
| Scott, BB; Vautier, G | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ; van Unnik, AJ | 1 |
| Barrett, DA; Erah, PO; Goddard, AF; Shaw, PN; Spiller, RC | 1 |
| Choi, CH; Chung, EC; Kung, NN; Kwok, SP; Li, TH; Lim, BH; Ma, HC; Ng, PW; Sung, JJ; Wong, KC; Yuen, NW | 1 |
| Labenz, J | 1 |
| Adachi, H; Ahmed, T; Hori, T; Matsubara, T; Nakahara, A; Sumazaki, R; Takita, H; Yamada, M | 1 |
| Akahane, T; Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Shimizu, T | 1 |
| Boyle, S; Jacyna, M; Martin, J | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M | 1 |
| Aubert, E; Berge, T; Efskind, PS; Haug, JB; Hauge, T; Henriksen, M; Lerang, F; Moum, B; Nicolaysen, K; Odegaard, A; Ragnhildstveit, E; Søberg, T; Tolås, P | 1 |
| Jönsson, KA; Sörberg, M; Ström, M | 1 |
| Peterson, WL | 1 |
| Anania, MC; Annibale, B; D'Ambra, G; Delle Fave, G; Iannoni, C; Luzzi, I; Marcheggiano, A; Marignani, M; Paoletti, M | 1 |
| Kimura, M; Seki, H; Urakami, Y | 1 |
| Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Biemond, I; Götz, JM; Lamers, CB; Offerhaus, GJ; Thio, JL; Veenendaal, RA; Verspaget, HW | 1 |
| Dmitrović, B; Horvat, D; Ivandić, A; Kovacić, D; Mićunović, N; Mihaljević, S; Paulini, D; Vcev, A; Vceva, A; Volaric, M; Vuković, D | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Alvarez, I; Bellas, C; Boixeda, D; Calleja, JL; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Breuer, T; Genta, RM; Graham, DP; Graham, DY; Gurer, IE; Kim, JG; Osato, M | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; García Plaza, A; Gisbert, JP; Martín De Argila, C | 1 |
| Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S | 1 |
| Bobrzyński, A; Rudnicka, L; Stachura, J | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Kobler, E; Reinhart, WH; Werth, B; Wüst, W | 1 |
| Barrett, DA; Goddard, AF; Jessa, MJ; Shaw, PN; Spiller, RC | 1 |
| Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
| Jónap, F; Patrik, E; Szántó, D; Szücs, G | 1 |
| Blazquez, M; Chaumette, MT; Delchier, JC; Haioun, C; Hammel, P; Lamarque, D; Lévy, M; Marty, O | 1 |
| Baker, A; Frantz, JE; Laine, L; Neil, GA | 1 |
| Chesters, SA; Copeman, MB; Cottrill, MR; Mason, I; McKinnon, C; Slatcher, G; Turbitt, ML | 1 |
| Attili, AF; Diana, F; Pugliano, F; Rinaldi, V; Valente, C; Zullo, A | 1 |
| el-Zimaity, HM; Graham, DP; Graham, DY; Hoffman, J; Osato, M | 1 |
| Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H | 1 |
| Buckley, MJ; Hyde, DM; Keane, CT; O'Morain, CA; Xia, HX | 1 |
| Altin, M; Dinc, I; Dobrucali, A; Eralp, YT; Goksel, S; Tuncer, M | 1 |
| Aoyagi, K; Fujishima, M; Hizawa, K; Kawasaki, M; Nakamura, S | 1 |
| Adamek, RJ; Pfaffenbach, B; Szymanski, C | 2 |
| Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Haber, M; Kidd, S; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Moayyedi, P | 2 |
| Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M | 1 |
| de Boer, WA; Driessen, WM; Lai, JY; Schneeberger, PM; van de Wouw, BA; van Etten, RJ | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Bhutta, AS; Bindel, H; Cunnane, K; Loane, J; O'Connor, HJ | 1 |
| Bielański, W; Bobrzyński, A; Budzyński, A; Gedliczka, O; Konturek, S; Stachura, J | 2 |
| Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Seki, M; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
| Berge, T; Haug, JB; Lerang, F; Moum, B; Sandvei, PK; Tolås, P; Torp, R; Tønnesen, T | 1 |
| Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y | 1 |
| Fennerty, MB | 1 |
| Cockeram, A; Hunt, RH; Jewell, D; Malatjalian, D; Matisko, A; Schep, G; Sidorov, J; Veldhuyzen van Zanten, S | 1 |
| Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D | 2 |
| Barkun, AN; De Souza, E; Fallone, CA; Lavallée, J; Loo, VG | 1 |
| Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L | 1 |
| Archimandritis, A; Balatsos, V; Davaris, P; Delis, V; Kanellopoulou, E; Manika, Z; Skandalis, N; Souyioultzis, S; Tzivras, M | 1 |
| Dmitrović, B; Gardasanić, J; Horonitz, M; Ivandić, A; Karner, I; Micunović, N; Mihaljević, S; Takac, B; Vcev, A; Vceva, A; Vuković, D | 1 |
| Hamilton, W; Price, J | 1 |
| Berquist, WE | 1 |
| Abraira, V; Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Redondo, C | 1 |
| Leri, O; Losi, T; Mastropasqua, M; Perinelli, P; Tubili, S | 1 |
| Ardill, JE; el-Nujumi, A; McColl, KE; Oien, K; Williams, C | 1 |
| Dankert, J; Homan, A; Roorda, P; Tytgat, GN; van der Ende, A; van der Hulst, RW | 1 |
| El-Zimaity, HM; Graham, DY; Kim, JG; Osato, MS; Perng, CL | 1 |
| Collins, BJ; Coombs, GW; Forbes, GM; McCullough, CA; Robins, PD | 1 |
| Daikeler, R; Glaser, J; Hein, J; Schmidt, M; Stolte, M; Vieth, M; Weithofer, G | 1 |
| Ammon, S; Klotz, U; Schneider, E; Treiber, G | 1 |
| Carnicer, J | 1 |
| Hibi, K; Imaizumi, H; Koizumi, W; Ohida, M; Okabe, H; Okayasu, I; Saigenji, K; Tanabe, S | 1 |
| Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ | 1 |
| de Boer, WA; Schneeberger, PM; van Etten, RJ | 1 |
| Huang, AH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Barbet, JP; Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J | 1 |
| Archimandritis, A; Katsorida, M; Souyioultzis, S; Tzivras, M | 1 |
| Ducóns, JA; Fuentes, J; García, S; Gimeno, L; Gomollón, F; Montoro, M; Vera, J | 1 |
| Calvet Calvo, X | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Navarro, M | 1 |
| Ara, JR; Bertol, V; Brieva, L; Canellas, A; del Agua, C | 1 |
| Dickson, A; el-Nujumi, A; el-Omar, EM; Hilditch, TE; Kelman, AW; McColl, KE; Murray, LS | 1 |
| Dmitrović, B; Kovac, D; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Cheah, PL; Chin, SC; Chuah, SY; Goh, KL; Lo, YL; Parasakthi, N | 1 |
| de Boer, SY; Siem, TH | 1 |
| Ahuja, V; Bal, C; Dhar, A; Sharma, MP | 1 |
| Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J; Senouci, L | 1 |
| Da Silva, CM; David, FL; De Nucci, G; Ferraz, JG; Mendes, FD; Moreno, H; Muscara, MN; Pedrazzoli, J | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Coremans, A; de Boer, WA; Schneeberger, PM; van Etten, RJ | 1 |
| Adler, G; Ellenrieder, V; Fensterer, H; Glasbrenner, B; Waurick, M | 1 |
| Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB | 1 |
| Branicki, FJ; Choi, HK; Chu, KM; Law, SY; Tuen, HH; Wong, J | 1 |
| Ho, AS; Hsu, CT; Huang, WH; Lee, MM; Lee, SC; Shyu, RY | 1 |
| Doermann, HP; Mégraud, F | 1 |
| Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
| Adamek, RJ; Bethke, TD | 1 |
| Maeda, K; Nishimura, H; Oda, K; Ohkuma, K; Okabe, N; Okada, M; Oki, K; Seo, M; Shirotani, T | 1 |
| Alfvén, G; Bergström, M; Casswall, TH; Dahlström, KA; Drapinski, M | 1 |
| Buckley, SJ; Jiang, Y; Kapoor, H; Little, R; Pollak, PT; Veldhuyzen van Zanten, SJ; Yeung, PK | 1 |
| Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F | 1 |
| Pigatto, P; Valsecchi, R | 1 |
| Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C | 2 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Hilditch, T; Kelman, A; Knill-Jones, R; McColl, K; Murray, L; Penny, C; Wirz, A | 1 |
| Chan, CC; Chen, TK; Huang, SH; Lee, CL; Lee, SC; Tu, TC; Wu, CH | 1 |
| Chan, FK; Chan, HL; Chung, SC; Lai, AC; Lau, JY; Lee, YT; Leung, WK; Ng, EK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Bock, H; Domschke, W; Heep, M; Kirchner, T; Lehn, N; Pohle, T; Stoll, R | 1 |
| Boixeda, D; Gisbert, JP; Martín de Argila, C | 1 |
| Bardhan, KD; Bayerdörffer, E; Cederberg, C; Hellblom, M; Lind, T; Mégraud, F; O'morain, C; Spiller, R; Unge, P; Veldhuyzen Van Zanten, S; Wrangstadh, M; Zeijlon, L | 1 |
| Klinkenberg-Knol, EC; Kuipers, EJ | 1 |
| Brullet, E; Calvet, X; Campo, R; Rué, M | 1 |
| Chua, AB; Cutler, A; Ding, RP; Goh, KL; Kandasami, P; Mazlam, MZ; Raj, SM | 1 |
| Fujita, R; Kirihara, K; Kojima, T; Sakurai, K; Takahashi, H; Yamada, M; Yamaguchi, Y | 1 |
| Iijima, K; Kato, K; Ohara, S; Sekine, H | 1 |
| Iwasaki, A | 2 |
| Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
| Kihira, K; Kimura, K; Kumakura, Y; Sato, K; Sugano, K; Yoshida, Y | 1 |
| Nilsson, F; Walder, M | 1 |
| Batey, RG; Henry, A | 1 |
| Unge, P | 2 |
| Navuluri, R; Yue, S | 1 |
| Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L | 1 |
| Chan, CK; Ching, CK; Ho, J; Hu, WH; Lai, CL; Lai, KC; Lam, SK; Lau, GK; Wong, BC; Yuen, ST | 1 |
| Blanchard, J; Boden, J; Ermak, T; Georgakopoulos, K; Giannasca, P; Gray, H; Hill, J; Ingrassia, J; Kleanthous, H; Lee, CK; Monath, TP; Soike, K; Tibbitts, T; Weltzin, R | 1 |
| Cheybani, K; Estrada, R; Laine, L; Neil, G; Smith, S; Trujillo, M; Yeramian, P | 1 |
| Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR | 1 |
| Breslin, NP; Buckley, MJ; Hyde, DK; Lee, JM; O'Morain, CA | 1 |
| Axon, AT; Everett, S; Langworthy, H; Mapstone, NP; Moayyedi, P; Neville, PM; Tompkins, D | 1 |
| Goddard, AF; Lawes, S; Logan, RP; Spiller, RC | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M; Valerio, G | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Chodash, HB; Dawson, BK; Luca, S; Michalos, A; Terranova, R | 1 |
| Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Bhasin, DK; Ray, P; Sharma, BC; Singh, K; Sinha, SK; Vaiphei, K | 1 |
| Are, BM; Atzei, A; Carta, M; Cugia, L; Dore, MP; Graham, DY; Maida, A; Manca, A; Massarelli, G; Mura, I; Piana, A; Realdi, G | 1 |
| Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H | 1 |
| Kawashima, M; Maeda, K; Nishimura, H; Ohkuma, K; Okabe, N; Okada, M; Seo, M; Takata, T | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Ende, AV; Hensen, EF; Hoff, BW; Houben, MH; Hulst, RW; Kate, FJ; Rauws, EA; Tytgat, GN | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H | 1 |
| Zwimpfer, J | 1 |
| Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
| Bardhan, KD; Bayerdörffer, E; Delchier, JC; Díte, P; Lind, T; Mégraud, F; O'Morain, C; Sipponen, P; Spiller, R; Veldhuyzen van Zanten, S; Zeijlon, L | 1 |
| Spiller, RC | 1 |
| Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Zagari, M | 1 |
| Angeles Arpa, M; Bermejo, F; Boixeda, D; García Arata, I; García Plaza, A; Gisbert, JP; Jesús Higes, M; Martín de Argila, C; Nieves Rincón, M | 1 |
| Ates, Y; Cetin, C; Dagalp, K; Erdil, A; Gulsen, M; Kadayifci, A; Karaeren, N; Uygun, A | 1 |
| Ariyama, I; Furusyo, N; Hayashi, J; Kanamoto, K; Kashiwagi, S; Nakamura, S; Suekane, H; Yano, Y; Yao, T | 1 |
| Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD | 1 |
| de Boer, WA; de Grauw, WJ; Lai, JY | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Adamsson, I; Edlund, C; Lundquist, P; Nord, CE; Sjöstedt, S | 1 |
| Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Bayerdörffer, E; Burman, CF; Díete, U; Dité, P; Domján, L; Kisfalvi, I; Lonovics, J; Mégraud, F; Pap, A; Sipponen, P; Zeijlon, L | 1 |
| Annibale, B; D'Ambra, G; Delle Fave, G; Marcheggiano, A; Martino, G; Paoletti, M | 1 |
| Ducóns, JA; Ferrero, M; García Cabezudo, J; Gomollón, F; Guirao, R; Montoro, M; Simón, MA | 1 |
| Chott, A; Mannhalter, C; Pfeffel, F; Pohl, G; Raderer, M; Valencak, J | 1 |
| Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| Chang, FY; Chau, WK; Fen-Yau Li, A; Huang, CC; Lam, CP; Lee, SD; Ng, WW | 1 |
| Hoshiya, S; Ishida, H; Itoh, T; Ninomiya, H; Saito, S; Shingaki, M; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI | 1 |
| De Boer, WA; Jansen, JB; Schneeberger, PM; Van De Wouw, BA; Van Etten, RJ; Van Oijen, AH | 1 |
| Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M | 1 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Kelman, A; McColl, KE | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Opekun, AR; Osato, MS | 1 |
| Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD | 1 |
| Chelvam, P; Fock, KM; Lim, SG | 1 |
| Chiba, N; Marshall, CP | 1 |
| Akamatsu, T; Furihata, K; Miyabayashi, H; Shimizu, T; Ueno, I | 1 |
| Gurer, I; Hilmioglu, F; Ozyilkan, E; Sare, M; Taskin, V | 1 |
| Dammann, HG; Fölsch, UR; Hahn, EG; Kirchner, T; Kist, M; Klör, HU; Strobel, S; von Kleist, DH | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| de Boer, WA; Nouhan, N; Plaisier, AP; Quint, WG; Schneeberger, PM; van Doorn, LJ | 1 |
| Bayerdörffer, E | 1 |
| Bielański, W; Karczewska, E; Konturek, SJ; Pytko-Polonczyk, J; Sliwowski, Z; Szlachcic, A | 1 |
| Berkowitz, D; Naveh, Y; Rosenthal, E; Shamaly, H | 1 |
| Fitscha, P; Schweeger, I; Sinzinger, H | 1 |
| Brousal, A; Kearney, DJ | 1 |
| Begum, S; Endo, H; Kawamata, H; Sano, T; Urakami, Y | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Adamsson, I; Edlund, C; Nord, CE | 1 |
| Andersen, LP; Colding, H; Kristiansen, JE | 1 |
| Azuma, T; Ito, S; Ito, Y; Kato, T; Kuriyama, M; Miyaji, H; Suto, H; Yamazaki, Y | 1 |
| Balta, A; Bouzakis, H; Broutet, N; Kralios, N; Michopoulos, S; Tsibouris, P; Vougadiotis, J | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Opekun, AR; Osato, MS | 1 |
| Adamthwaite, D; Davidson, G; Katelaris, PH; Lambert, J; Midolo, P; Yeomans, ND | 1 |
| Ammon, S; Kees, F; Klotz, U; Treiber, G | 1 |
| Iida, N; Kurosawa, A; Miwa, H; Nagahara, A; Ogawa, K; Ohkura, R; Sato, N | 1 |
| Bratović, I; Gogov, B; Gribajcević, M; Lacević, N; Radović, S; Vukobrat-Bijedić, Z | 1 |
| Imai, T; Konno, M; Muraoka, S; Takahashi, M | 1 |
| Grundmeijer, HG; Hurenkamp, GJ; Tytgat, GN; Van Der Ende, A; Van Der Hulst, RW | 1 |
| Mansi, C; Savarino, V; Vigneri, S | 1 |
| Gribajcević, M; Pasalić, G; Salaka, U; Vanis, N | 1 |
| Barrera, F; Fuentes, J; Garuz, R; Gomollón, F; Malo, J; Simón, MA; Tirado, M; Valdepérez, J | 1 |
| Piqué, JM | 1 |
| Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R | 1 |
| Buzás György, M; Illyés, G; Székely, E; Széles, I | 1 |
| Castro Fernández, M; Grande, L; Martínez Delgado, C; Otero Fernández, MA; Romero Gómez, M; Vargas, J | 1 |
| Huang, AH; Huang, CC; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Cheah, P; Chin, S; Goh, K; Parasakthi, N; Ranjeev, C; Rosmawati, M; Tan, Y | 1 |
| Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R | 1 |
| Bezborodnyĭ, SD | 1 |
| Aalykke, C; Bekker, C; Bonnevie, O; Bytzer, P; Eriksen, J; Gjørup, T; Hansen, J; Justesen, T; Kjaergaard, J; Kromann-Andersen, H; Rask-Madsen, J; Rune, S; Teglbjaerg, PS; Vilien, M; Vyberg, M; Weywadt, L | 1 |
| Begum, S; Endo, H; Kawamata, H; Oki, Y; Sano, T; Urakami, Y | 1 |
| Aydin, A; Isler, M | 1 |
| Cheng, NN; Hu, PJ; Liu, WZ; Ouyang, Q; Wang, JL; Xiao, SD; Zhou, LY | 1 |
| Baena Díez, JM; García Lareo, M; López Mompó, C; Rams Rams, F; Rosario Hernández Ibáñez, M; Teruel Gila, J | 1 |
| García, S; Gomollón, F; Lago, A; Sicilia, B; Sierra, E; Villar, M | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Adamsson, I; Edlund, C; Engstrand, L; Seensalu, R | 1 |
| Rosandić, M | 1 |
| Bardhan, K; Bayerdörffer, E; Burman, CF; Delchier, JC; Gromark, P; Hellblom, M; Lind, T; Mégraud, F; Stubberöd, A; Veldhuyzen Van Zanten, SJ; Zeijlon, L | 1 |
| Andriulli, A; Bergoli, ML; Caruso, N; Clemente, R; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST | 1 |
| Alizadeh, BZ; Fakheri, H; Fazel, A; Khatibian, M; Malekzadeh, R; Massarrat, S; Merat, S | 1 |
| Kurosawa, A; Miwa, H; Nagahara, A; Ohkura, R; Sato, N; Yamada, T | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Okimoto, T; Satoh, R | 1 |
| Ohkusa, T; Watanabe, M | 1 |
| Chan, FK; Chan, HL; Chung, SC; Hui, Y; Lai, MS; Lau, JY; Lee, YT; Leung, VK; Leung, WK; Suen, BY; Sung, JJ; Wu, JC | 1 |
| El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Osato, MS; Saeed, MA | 1 |
| Avidan, B; Bar-Meir, S; Keller, N; Melzer, E | 1 |
| Konorev, MR | 1 |
| Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Axon, AT; Barrowclough, S; Crocombe, W; Moayyedi, P; Neville, PM; Wrangstadh, M | 1 |
| Della Libera, E; Ferrari, AP; Moraes, M; Rohr, MR; Siqueira, ES | 1 |
| Chan, CK; Chu, KM; Fung, FM; Hu, FL; Hu, WH; Hui, WM; Kung, NN; Lai, KC; Lam, SK; Lau, GK; Liu, XG; Wang, WH; Wong, BC; Wong, WM; Yuen, MF | 1 |
| Drewe, J; Geiser, HR; Meier, R; Wettstein, A | 1 |
| Brullet, E; Calvet, X; Campo, R; Garcia, N; Gené, E; Sanfeliu, I | 1 |
| Delves, HT; Doig, LA; Phillips, RH; Powell, JJ; Sieniawska, CE; Thompson, RP; Whitehead, MW | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T | 1 |
| Bateson, MC | 1 |
| Chan, KL; Ng, DK; Tam, PK; Zhou, H | 1 |
| Ell, C; Moser, W; Ridl, W; Schoerner, C; Solbach, W; Stolte, M; Vieth, M | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Barton, R; Campbell, M; Eccles, M; Hall, L; Steen, N | 1 |
| Aoyama, N; Hohda, T; Kasuga, M; Kita, T; Komada, F; Okumura, K; Saijoh, Y; Sakaeda, T; Sakai, T; Tanigawara, Y | 1 |
| Bentivoglio, AR; Carloni, E; Cicconi, V; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Manna, R; Nocente, R; Servidei, S; Silveri, NG | 1 |
| Fedorov, AV; Sazhin, VP | 1 |
| Antonenko, OM; Dicheva, DT; Lebedev, EG; Maev, IV; Ovsiannikova, EV; Shchekina, MI; V'iuchnova, ES | 1 |
| Kullavanijaya, P; Mahachai, V; Phaosawadi, K; Vilaichone, RK; Wongkusoltham, P | 1 |
| Burm, M; Faigel, D; Fennerty, MB; Kelly, C; Magaret, N; Peterson, W | 1 |
| Bühling, A; Malfertheiner, P; Müller, WA; Radun, D | 1 |
| Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC | 1 |
| Archambault, A; Bailey, R; Dallaire, C; Desrochers, S; Dumont, A; Fallone, CA; Farley, A; Hunt, R; Lahaie, R; Marcon, N; Nguyen, B; Oravec, M; Ponich, T; Spénard, J; Van Zanten, SV; Whitsitt, P | 1 |
| Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
| Fuchs, KH; Greiner, A; Sailer, M; Timm, S | 1 |
| Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F | 1 |
| Baeva, N; Ianev, N; Kiselova, A; Krŭstev, D; Krŭstev, N; Vichev, E | 1 |
| Kaddu, S; Kränke, B; Mayr-Kanhäuser, S; Müllegger, RR | 1 |
| Veldhuyzen van Zanten, SJ | 1 |
| Farkkilä, M; Koskenpato, J; Sipponen, P | 2 |
| Chen, CL; Chen, LT; Cheng, AL; Chiang, IP; Jan, CM; Lin, JT; Liu, SM; Shyu, RY; Su, IJ | 1 |
| Esaki, M; Fukuda, T; Kurahara, K; Kusano, Y; Matsumoto, T; Nakamura, S | 1 |
| Corder, FA; Howden, CW; Sahai, AV; Sharma, VK | 1 |
| Alpen, B; Neubauer, A; Röbbecke, J; Stolte, M; Wündisch, T | 1 |
| Akao, T; He, JX; Nishino, T; Tani, T | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Messerer, P; Ott, MG; Riemann, JF; Schauwecker, P; Schilling, D; Zober, A | 1 |
| Asgari, AA; Dariani, NE; Malekzadeh, R; Massarrat, S; Sotoudehmanesh, R; Vahedi, H | 1 |
| Alampi, G; Bazzoli, F; Berretti, D; De Luca, L; Di Pietro, C; Fossi, S; Morelli, P; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, E; Zagari, RM | 1 |
| Chang, CS; Chen, GH; Lai, CH; Poon, SK; Su, J; Wang, WC; Yang, CC | 1 |
| Brousse, N; Copie-Bergman, C; de Mascarel, A; Delchier, JC; Flejou, JF; Gaulard, P; Hemery, F; Lavergne-Slove, A; Levy, M; Traulle, C | 1 |
| Burton, MP; Narayani, RI; Young, GS | 1 |
| Haapiainen, R; Härkönen, M; Kokkola, A; Kosunen, TU; Puolakkainen, P; Rautelin, H; Sipponen, P | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C; Triantafyllou, K | 1 |
| Barbier, C; Benhamou, PH; Bergeret, M; Dupont, C; Gottrand, F; Husson, MO; Kalach, N; Raymond, J | 1 |
| Andersen, LP; Chen, M; Colding, H; Jensen, B; Kharazmi, A; Kristiansen, JE; Zhai, L | 1 |
| Chiba, N; Escobedo, S; Ferguson, RA; Grace, E; Sinclair, P; Van Zanten, SJ | 1 |
| Kato, S | 1 |
| Satoh, K | 1 |
| Fu, HY; Kawano, S; Tanimura, H | 1 |
| Ohkusa, T; Sato, N | 1 |
| Miwa, H; Miyazaki, A; Nagahara, A; Sato, N | 1 |
| Takahashi, S; Tokunaga, K | 1 |
| Ishitobi, H; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Inoue, K; Sugano, K | 1 |
| Hiraishi, H; Kanke, K; Terano, A | 1 |
| Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
| Isomoto, H; Kohno, S | 1 |
| Dore, MP; Graham, DY; Manca, A; Marras, L; Mele, R; Nieddu, S; Realdi, G | 1 |
| Kapp, A; Wedi, B | 1 |
| Calvet, X; Gisbert, JP; Vallve, M; Vergara, M | 1 |
| Kato, K; Nagura, H; Noguchi, K; Ohara, S; Sekine, H; Shimosegawa, T; Suzuki, T | 1 |
| Kolomiets, EV; Vasil'ev, IuV | 1 |
| Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A | 1 |
| Arand, F; Bayerdörffer, E; Klein, U; Knippig, C; Leodolter, A; Malfertheiner, P; Nilius, M | 1 |
| Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
| Domareva, I; Ganskaya, Z; Isakov, V; Koudryavtseva, L; Maev, I | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Bermejo, F; Boixeda, D; Defarges, V; García-Plaza, A; Hernández-Ranz, F; López-Sanromán, A; Martín-De-Argila, C; Milicua, JM | 1 |
| Fischbach, W; Goebeler-Kolve, M; Greiner, A; Müller-Hermelink, HK; Starostik, P | 1 |
| Firsanova, VIu; Kolomiets, EV; Vasil'ev, IuV; Zvenigorodskaia, LA | 1 |
| Vasil'ev, IuV; Zvenigorodskaia, LA | 1 |
| Bondarenko, OY; Fedchenko, VI; Grigoriev, PY; Gulyaev, PV; Ivashkin, VT; Lapina, TL; Sklanskaya, OA; Vasiliev, YV; Yakovenko, EP | 1 |
| Bevanda, M; Falisevac, V; Korać, B; Pilas, V; Rosandić, M | 1 |
| Chuang, CH; Huang, AH; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Fang, L; Huang, S; Jiang, K; Jiang, X; Lin, N; Pan, W; Wan, Y; Xu, R | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Cui, M; Hu, F; Jiang, H; Zheng, X | 1 |
| Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G | 1 |
| Rai, R; Rai, S | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S | 1 |
| Ala'Aldeen, DA; Jenks, PJ; Loughlin, MF | 1 |
| Sano, T; Urakami, Y | 1 |
| El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J | 1 |
| Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S | 1 |
| Lee, J; Machado, S; Veldhuyzen Van Zanten, S | 1 |
| Ekström, P; Hellblom, M; Kihira, K; Kimura, K; Ohlin, B; Satoh, K; Sipponen, P; Stubberöd, A; Unge, P; Yoshida, Y; Yube, T | 1 |
| Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
| Enjoji, A; Fujimoto, C; Furusu, H; Hirakata, Y; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Omagari, K; Shimada, S; Yamakawa, M | 1 |
| Nurbaev, FE; Orziev, ZM; Rakhimova, GSh | 2 |
| Ermolaev, IA; Nazarov, VE; Rukhliada, NV | 1 |
| Dore, MP; Graham, DY; Manca, A; Maragkoudakis, E; Marras, L; Nieddu, S; Realdi, G | 1 |
| Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| de Boer, SY; de Boer, WA; Siem, H; v d Meeberg, PC | 1 |
| Berg, DE; Chan, AO; Chan, CK; Fung, FM; Gu, Q; Hu, WH; Hui, CK; Lai, KC; Lam, SK; Wang, WH; Wong, BC; Wong, WM; Xia, HH; Yuen, MF | 1 |
| Andersson, DI; Blaser, MJ; Engstrand, L; Sjölund, M; Wreiber, K | 1 |
| Cisneros, G; Gurney, M; Jarjoura, D; Lara, LF; Moauro, B; Polen, A; Rutecki, G; Van Ness, M; Whittier, F | 1 |
| Barthelemy, P; Bretagne, JF; Courillon-Mallet, A; De Korwin, JD; Delchier, JC; Fauchère, JL; Fléjou, JF; Labigne, A; Lamouliatte, H; Mégraud, F | 1 |
| Bästlein, E; Bayerdörffer, E; Buchner, M; Ebert, S; Haferland, C; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W | 1 |
| Barbato, A; Landi, L; Panizzolo, C; Rugge, M; Semenzato, R | 1 |
| Il'chenko, LIu; Nazarenko, IV; Parfenov, AI; Ruchkina, IN; Zvenogorodskaia, LA | 1 |
| Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansia, C; Savarino, V; Usai, P; Vigneri, S; Zentilin, P | 1 |
| Dragosics, B; Fischbach, W; Goebeler-Kolve, ME; Greiner, A; Stolte, M | 1 |
| Vithayasai, N | 1 |
| Farup, PG | 1 |
| Chen, JS; Ching, CK; Feng, RE; Fong, DY; Ho, J; Hu, WH; Lai, KC; Lam, SK; Leung, SY; Wong, BC; Wong, WM; Yuen, ST; Zheng, TT | 1 |
| Armstrong, D; Barkun, A; Chiba, N; Escobedo, S; Grace, E; Lee, J; Sinclair, P; Thomson, AB; Veldhuyzen Van Zanten, SJ | 1 |
| Boyacioglu, S; Cosar, AM; Gumurdulu, Y; Gur, G; Gursoy, M; Kayaselcuk, F; Ozer, B; Ozsahin, K; Serin, E; Yilmaz, U | 1 |
| Cuomo, A; De Simone, T; Del Vecchio Blanco, C; Iovene, MR; Marmo, R; Montella, F; Mucherino, C; Nardone, G; Romano, M; Tufano, MA | 1 |
| Dunnett, M; Lees, P | 1 |
| Färkkilä, M; Sarna, S; Sipponen, P; Valtonen, V | 1 |
| Aumais, C; Lefebvre, M; Massicotte, J; Spénard, J; Tremblay, C | 1 |
| Baldwin, L; Bell, GD; Cameron, EAB; Jones, P; Powell, KU; Williams, SGJ | 1 |
| Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
| Iijima, K; Imatani, A; Koike, T; Ohara, S; Sekine, H; Shimosegawa, T | 1 |
| Hrdý, I; Kulda, J; Sutak, R; Tachezy, J | 1 |
| Granström, M; Hoang, TT; Nilsson, LE; Phuncarg, DC; Sörberg, M; Wheeldon, TU | 1 |
| Burroughs, R; Lane, E; Lobetti, R | 1 |
| Abudayyeh, S; Belson, G; Dore, MP; El-Zimaity, HM; Graham, DY; Osato, MS | 1 |
| Chen, XX; Ou, BY; Qü, YP; Shang, SQ; Tang, HF; Wu, XY; Zhou, XL | 1 |
| Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
| Ando, T; El-Omar, E; Goto, H; Ichiyama, S; Iinuma, Y; Ina, K; Kusugami, K; Minami, M; Nada, T; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
| Arslan, N; Bekem, O; Buyukgebiz, B; Hizli, S; Ozer, E; Ozturk, Y | 1 |
| Schluter, PJ; Wallace, RA; Webb, PM | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Choi, JH; Choung, RS; Chun, HJ; Han, WS; Hyun, JH; Jeen, YT; Jung, SW; Keum, B; Kim, CD; Kim, YS; Lee, HS; Lee, SW; Park, SC; Ryu, HS; Um, SH | 1 |
| de Boer, WA; Jansen, JB; Janssen, MJ; Laheij, RJ | 1 |
| Fukuda, S; Fukushi, M; Mikami, T; Munakata, A; Shimoyama, T | 1 |
| Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N | 1 |
| Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y | 1 |
| Asaoka, D; Hojo, M; Iijima, K; Kawabe, M; Kurosawa, A; Miwa, H; Miyazaki, A; Nagahara, A; Ohkusa, T; Sato, N; Terai, T | 1 |
| Casanovas, N; Elizalde, JI; Escolar, G; González, J; Heras, M; Lozano, M; Martorell, T; Pérez-Pujol, S; Piqué, JM; Sanz, G; Sionis, A | 1 |
| Chan, CK; Chen, MH; Cui, Y; Gu, Q; Hu, PJ; Hu, WH; Huang, JQ; Lai, KC; Lam, SK; Li, CJ; Wang, WH; Wong, BC; Wong, WM; Wu, SM; Xia, HH; Xiao, SD | 1 |
| Bellotti, M; Botta, F; Chiarbonello, B; Cotelessa, T; Emanuela, T; Fumagalli, A; Giannini, E; Malfatti, F; Milazzo, S; Podestà, E; Polegato, S; Testa, R | 1 |
| Bory, F; Calvet, X; Ducons, J; Guardiola, J; Marko, D; Tito, L | 1 |
| Chang, FY; Chen, CY; Lee, SD; Lu, CL; Lu, RH; Luo, JC | 1 |
| Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME | 1 |
| Amini, M; Khedmat, H; Yari, F | 1 |
| Cao, DZ; Fu, XL; Hu, JM; Ou, XL; Su, H; Sun, WH; Sun, YL; Yu, Q; Yu, T; Zhu, F | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Bar-Meir, M; Benenson, S; Faber, J; Halle, D; Rachman, E; Rudensky, B; Schlesinger, Y; Sirota, G; Stankiewic, H; Wilschanski, M | 1 |
| Shao, Y; Yu, ZL; Zhang, L; Zhang, ST | 1 |
| Chan, AO; Chan, CK; Cheung, KL; Fung, FM; Ho, VY; Huang, J; Hui, CK; Lai, KC; Lam, SK; Tong, TS; Wong, BC; Wong, WM; Xia, HH | 1 |
| Botta, F; Fumagalli, A; Giannini, EG; Malfatti, F; Mamone, M; Polegato, S; Savarino, V; Testa, E; Testa, R | 1 |
| Bonner, RA; Delaney, KH; Gee, LC; Jury, J; Perdue, MH | 1 |
| Bayeli, PF; Cerretani, D; Giorgi, G; Marzocca, G; Pellegrini, M; Urso, R | 1 |
| Abasiyanik, MF; Huten, O; Salih, BA; Sander, E; Saribasak, H | 1 |
| Dmitrović, B; Horvat, D; Ivezić, Z; Kraljik, N; Misević, T; Soldo, I; Timarac, J; Vcev, A | 1 |
| Chen, CL; Chen, GH; Chen, LT; Cheng, AL; Jan, CM; Kuo, SH; Lin, JT; Sheu, BS; Su, IJ; Tai, JJ; Wang, HP; Wang, TE; Wang, WM; Whang-Peng, J; Wu, CW; Yang, SS; Yeh, HZ | 1 |
| Baggett, HC; Bruce, MG; Dunaway, E; Gessner, BD; Gold, BD; Muth, PT; Parkinson, AJ | 1 |
| Foucar, MK; Pai, RK; Snider, WK; Starkey, CR; Viswanatha, D; Wilson, CS | 1 |
| Borody, TJ | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Asaka, M | 1 |
| Fujioka, T | 1 |
| Nagahara, A; Sato, N | 1 |
| Fujioka, T; Murakami, K; Okimoto, T | 1 |
| Furuta, T; Nakamura, A; Shirai, N; Sugimoto, M | 1 |
| Bray, R; Hiratsuka, H; Hiratsuka, T; Kimura, K; Suzuki, T; Tamura, K | 1 |
| Fujishiro, M; Kobayashi, K; Oka, M; Omata, M | 1 |
| Asaka, M; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y | 1 |
| Konno, M | 1 |
| Katoh, H; Kuwano, H; Miyazaki, T; Tsukada, K | 1 |
| Abe, C; Hikichi, T; Irisawa, A; Obara, K; Sato, Y | 1 |
| Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK | 1 |
| Borody, TJ; Clancy, R; Herdman, K; Llorente, R; Ng, C; Pang, G; Surace, R; Wettstein, AR | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Hirakawa, K; Ishikawa, T; Katsuragi, K; Maeda, K; Mino, A; Ohira, M; Onoda, N; Sawada, T; Wakasa, K | 1 |
| Postavnyĭ, VE | 1 |
| Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 2 |
| Castro-Fernández, M; Cosme, A; Gisbert, JP; Gómez, B; Herrerías, JM; Luna, M; Monés, J; Olivares, D; Pajares, JM; Sánchez-Pobre, P | 1 |
| Aghakhani, S; Bahremand, S; Fourutan, H; Mir, E; Nematollahi, LR; Nouripour, S; Tirgari, F | 1 |
| Quandalle, P; Tran, TT | 1 |
| Díte, P; Dostalík, Z; Hegyi, P; Hůlek, P; Králová, Z; Kunovská, M; Kyzeková, J; Matejovic, F; Novotný, I; Pásková, J; Petrtýl, J; Procházka, V; Pulgretová, D; Samek, M; Vyhnálek, P; Weinberg, J; Woznica, V; Zelenková, J | 1 |
| Classen, M; Li, J; Lin, SR; Liu, WD; Ma, JL; Pan, KF; Shen, L; Xiao, SD; You, WC; Zhang, L | 1 |
| Bästlein, E; Bayerdörffer, E; Hansky, K; Jacobs, E; Kirsch, C; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M | 1 |
| Mousavi, S; Toussy, J; Yaghmaie, S; Zahmatkesh, M | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Abouzari, M; Hasibi, M; Mirbagheri, SA; Rashidi, A | 1 |
| Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A | 1 |
| Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N | 1 |
| Alizadeh, M; Arj, A; Bagheri-Lankarani, K; Bahri-Najafi, R; Dehbashi, N; Emami, MH; Esmaeili, A; Fattahi, MR; Geramizadeh, B; Kaviani, MJ; Saberfiroozi, MM; Taghavi, AR | 1 |
| Bella, A; Caracciolo, F; Crispino, P; Gurnari, M; Iacopini, F; Nardi, F; Paoluzi, P; Pica, R; Rivera, M; Rossi, P; Zippi, M | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Gover, MD; Graber, M; Gupta, AK; Hollis, S; van Zuuren, EJ | 1 |
| Chang, WC; Chu, SJ; Tsai, SH; Wu, CP | 1 |
| Ardengh, JC; Domene, CE; Morrell, AC; Valiati, LH | 1 |
| Tepes, B | 1 |
| Dorchy, H; Khalil, T; Melot, C; Scaillon, M | 1 |
| Chung, SJ; Hwang, JH; Jung, HC; Jung, SH; Kim, JW; Kim, N; Lee, DH; Lee, KH; Park, YS; Song, IS | 1 |
| Cabrera, E; Castro, M; Fernández, N; Méndez, I; Moreno, JL; Navarro-Jarabo, JM; Perea-Milla, E; Ramírez, LM; Rivas-Ruiz, F; Rivera, R; Sousa, FL; Ubiña, E; Vera, F | 1 |
| Chen, XY; Ge, ZZ; Li, XB; Liu, WZ | 1 |
| Engstrand, L; Fall, K; Fjelstad, B; Jakobsson, H; Nyrén, O; Wreiber, K | 1 |
| Mahachai, V; Thong-Ngam, D | 1 |
| Hanemaaijer, R; Kubben, FJ; Lamers, CB; Schram, MT; Sier, CF; van Duijn, W; Veenendaal, RA; Verheijen, JH; Verspaget, HW; Witte, AM | 1 |
| Gisbert, JL; Gisbert, JP; Jimenez-Alonso, I; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K | 1 |
| Bergeret, M; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Hallas, J; Hansen, JM; Schaffalitzky de Muckadell, OB; Wildner-Christensen, M | 1 |
| Nijawan, S; Rishi, JP; Yadav, MK | 1 |
| Baker, DE | 1 |
| Baek, YH; Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Park, SK; Sohn, CI; Song, MJ | 1 |
| Blumenthal, M; Bornstein, J; Geva, A; Geva, H; Levy, J; Ophir, E; Sabo, E | 1 |
| Egan, BJ; O'Connor, HJ; O'Morain, CA | 1 |
| Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA | 1 |
| Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
| Aladag, I; Erkokmaz, U; Eyibilen, A; Guven, M | 1 |
| Abd El-Hamed, TM; El Awady, S; El-Nakeeb, A; Farid, M; Fikry, A; Fouda, el Y; Sherief, D; Youssef, T | 1 |
| Bago, J; Bago, P; Bakula, V; Marusić, M; Pevec, B; Tomić, M | 1 |
| Abdou, AG; Elnaidany, NF; Elshayeb, EI; Farag, AG | 1 |
| Derakhshan, F; Haghazali, M; Mirsattari, D; Mohsenian, N; Molaei, M; Talaie, R; Zali, MR; Zojaji, H | 1 |
| Ansari, T; El-Hasani, S; Hussain, A; Mahmood, H | 1 |
| Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L | 1 |
| O'Connor, HJ; O'Morain, CA; Qasim, A; Saleem, A | 1 |
| Bennett, AE; He, X; Lian, L; Shen, B | 1 |
| Classen, M; Liu, W; Ma, J; Pan, K; Winawer, S; You, W; Zauber, A; Zhang, L; Zhao, H; Zhou, T | 1 |
| Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
| Andersson, AF; Engstrand, L; Jakobsson, HE; Jansson, JK; Jernberg, C; Sjölund-Karlsson, M | 1 |
| Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
| Changsom, D; Chawansuntati, K; Koosirirat, C; Linpisarn, S; Wipasa, J | 1 |
| Brown, CA; Ellis, AE; Miller, DL | 1 |
| Beck, SE; Brayton, C; Del Carmen Martino-Cardona, M; Watson, J | 1 |
| Ae, T; Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Nishimura, K; Saigenji, K; Sasaki, T; Tanabe, S | 1 |
| Chen, WJ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L | 1 |
| Jamshidi, S; Khoshnegah, J; Mohammadi, M; Sasani, F | 1 |
| Abu-Alfotuh, A; Al Shabrawi, H; Allam, MA; El-Shafie, AM; Elwan, AM; Soliman, GM | 1 |
| Abbas, Z; Abid, S; Jafri, SN; Yakoob, J | 1 |
| Kim, N; Lee, BH | 1 |
| Bazzoli, F; Celiñski, K; Delchier, JC; Giguère, M; Malfertheiner, P; Mégraud, F; Rivière, M | 1 |
| Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
| Gisbert, JP | 1 |
| Bontems, P; Cadranel, S; Kalach, N; Miendje, DY; Muyshont, L; Oderda, G; Raymond, J; Salame, A; Scaillon, M | 1 |
| Geng, QM; Han, YJ; Tian, XL; Zhang, JZ; Zhou, LY | 1 |
| Kolber, MR; Korownyk, C | 1 |
| Bdioui, F; Ben Chaabane, N; Bouhlel, W; Hellara, O; Loghmari, H; Melki, W; Safer, L; Saffar, H; Zakhama, A | 1 |
| Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C | 1 |
| Agah, S; Ekhlasi, G; Ghourchian, S; Salehpour, A; Shidfar, F | 1 |
| Cardenas, VM; Dominguez, DC; Graham, DY; Reddy, RK; Salazar, CO; Snyder, LK | 1 |
| Chen, PY; Geng, LL; Gong, ST; He, WE; Huang, H; Huang, J; Liu, LY; Ou, WJ; Pan, RF; Zhou, LY | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, SA; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
| Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Ding, ZL; Geng, L; Gong, ST; Huang, J; Li, DY; Li, ZL; Mao, M; Wang, ZL; Xu, XW; Yang, M; Zhou, L | 1 |
| Mansour, GM; Nashaat, EH | 1 |
| Delchier, JC; Malfertheiner, P; Thieroff-Ekerdt, R | 1 |
| Fakharian, T; Ghanei, H; Hosseini, SM; Nazemian, F; Sharifipoor, F; Zivarifar, HR | 1 |
| Castillo-Villanueva, A; de la Mora-de la Mora, I; Enríquez-Flores, S; Figueroa-Salazar, R; García-Torres, I; Gómez-Manzo, S; Gutiérrez-Castrellón, P; Hernández-Alcántara, G; López-Velázquez, G; Marcial-Quino, J; Méndez, ST; Oria-Hernández, J; Reyes-Vivas, H; Torres-Arroyo, A; Vanoye-Carlo, A; Yépez-Mulia, L | 1 |
| Aisa, AP; Barrio, J; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Gisbert, JL; Gisbert, JP; Marcos, S; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Rodrigo, L | 1 |
| Aponte-Pieras, JR; Lee, DS; Morrissey, R; Moss, SF; Rogers, AB; Zhang, S | 1 |
| Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K | 1 |
| Brennan, DE; Breslin, N; Haider, RB; Hall, B; Holleran, G; McNamara, D; O'Connor, HJ; O'Morain, C; Omorogbe, J; Smith, SM | 1 |
| Akhtar, N; Asif, HM; Sugiyama, T; Usmanghani, K; Zaidi, SF | 1 |
| Belzer, C; de Vos, WM; den Dunnen, JT; Devilee, P; Dingemanse, C; Günthel, M; Kuijper, EJ; Robanus-Maandag, EC; Salvatori, D; van Hijum, SA; van Ommen, GB | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Amiot, A; Bastuji-Garin, S; Deforges, L; Delchier, JC; Le Thuaut, A; Muller, N | 1 |
| Amiri, M | 1 |
| Colak, Y; Doganay, L; Ozdil, K; Ozturk, O; Tuncer, I; Ulasoglu, C; Yilmaz Enc, F | 1 |
| Argüelles Arias, F; Castro Laria, L; Castro Márquez, C; Caunedo Álvarez, Á; Gómez Rodríguez, BJ; Romero Gómez, M | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Baghbanian, M; Mirvakili, M; Salmanroghani, H; Salmanroghani, R; Sanati, G; Yazdian, P | 1 |
| Agudo-Fernández, S; González Blanco, A | 1 |
| Bayingana, C; Dusabejambo, V; Hale, D; Hategeka, C; Kabakambira, JD; Ndoli, J; Ngabonziza, F; Ntirenganya, C; Page, C; Walker, T | 1 |
| Benkirane, A; Berrag, S; Berraida, R; Boutallaka, H; Elkoti, I; Loubaris, K; Nejjari, F; Seddik, H; Sentissi, S | 1 |
| Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
| Cholleti, SM; Jodesty, Y; Li, D; Pham, HV; Tseng, DS; Wei, JC | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Attia, TZ; Derayea, SM; Tsujino, H; Tsutsumi, Y; Uno, T; Yamashita, T | 1 |
| Bernardino, JI; Martín Carbonero, L; Montejano, R; Moreno, V; Serrano, L; Valencia, ME | 1 |
| Huang, Y; Jiang, Y; Tang, Z; Wang, Y; Yan, W; Ye, Z; Zhang, Y; Zhou, Y | 1 |
| Huang, Y; Lu, J; Lu, X; Miao, S; Sun, H; Wang, Y; Wu, J; Ye, Z; Zhou, Y | 1 |
| Calvo, PL; Cisarò, F; Pizzol, A | 1 |
| Graham, DY; Howden, CW | 1 |
| Ali, OT; Almalki, AJ; Hassan, WS; Khayyat, AN; Sebaiy, MM | 1 |
| Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y | 1 |
| Hassib, ST; Mostafa, EA; Sharf, MG; Taha, EA | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
57 review(s) available for omeprazole and metronidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent developments in anti-Trichomonas research: An update review.
Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections | 2018 |
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles | 2020 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1995 |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tinidazole | 1994 |
Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; United States | 1994 |
The role of acid inhibition in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric Acid; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1994 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Stomach Neoplasms; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Tetracycline; Time Factors | 1998 |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Proton Pump Inhibitors | 1998 |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 1998 |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 1999 |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1999 |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Patient Education as Topic; Stomach Ulcer; Sweden | 1999 |
Antibiotic treatment of Helicobacter pylori infection.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
[Selection of antibiotics and planning of eradication for H. pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2001 |
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Patient Compliance; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Metronidazole; Omeprazole; Penicillins; Placebos; Randomized Controlled Trials as Topic; Stomach Diseases; Stomach Ulcer; Tablets; Time Factors; Zollinger-Ellison Syndrome | 2001 |
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; MEDLINE; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Risk Factors; Salicylates; Sensitivity and Specificity | 2001 |
[Guidelines of Helicobacter pylori eradication in children].
Topics: Amoxicillin; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Europe; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; North America; Omeprazole; Pediatrics; Practice Guidelines as Topic | 2002 |
[New triple therapy for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2002 |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline | 2002 |
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome | 2002 |
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Omeprazole; Rabeprazole; Treatment Failure | 2002 |
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure | 2002 |
[Proton pump inhibitors: Omeprazole].
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Sucralfate].
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Sucralfate; Treatment Outcome; Urease | 2002 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
Helicobacter pylori infection in skin diseases: a critical appraisal.
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Omeprazole; Prognosis; Risk Factors; Severity of Illness Index; Skin Diseases, Bacterial; Urticaria | 2002 |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome | 2002 |
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic | 2004 |
[Guidelines in the management of H. pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; National Health Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 2005 |
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2005 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2005 |
[Investigation about 3rd line eradication of H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2005 |
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Treatment Outcome | 2005 |
Systematic review of rosacea treatments.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Benzoyl Peroxide; Cosmetics; Dicarboxylic Acids; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Metronidazole; Omeprazole; Permethrin; Randomized Controlled Trials as Topic; Research Design; Rosacea; Single-Blind Method; Sunscreening Agents; Tetracyclines; Treatment Outcome | 2007 |
Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
Topics: Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Capsules; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 2008 |
What is new in the management of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2008 |
Pylera for the eradication of Helicobacter pylori infection.
Topics: Administration, Oral; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Capsules; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic; Tetracycline; Treatment Outcome | 2009 |
340 trial(s) available for omeprazole and metronidazole
| Article | Year |
|---|---|
Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Single-Blind Method; Tetracycline | 1992 |
Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Risk Factors; Sucralfate; Tetracycline | 1992 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1991 |
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline | 1995 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Recurrence | 1995 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Magnesium Hydroxide; Metronidazole; Omeprazole; Simethicone; Stomach Ulcer; Tetracycline | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Topics: Adult; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Sucralfate; Tetracycline | 1995 |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1995 |
Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Recurrence | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Tetracycline; Treatment Outcome | 1994 |
Rapid eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Chi-Square Distribution; Cost-Benefit Analysis; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1995 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Stomach Ulcer; Tetracycline | 1995 |
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1995 |
Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Topics: Antacids; Biopsy; Bismuth; DNA; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Omeprazole; Oxytetracycline; Stomach | 1994 |
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Recurrence; Statistics as Topic; Tetracycline | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach; Stomach Ulcer; Stomatitis; Sulfoxides | 1995 |
Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline; Time Factors | 1995 |
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Topics: Adult; Aged; Antacids; Biopsy; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pain; Stomach Diseases; Tetracycline; Wound Healing | 1994 |
Causal role of Helicobacter pylori in peptic ulcer relapse.
Topics: Aged; Amoxicillin; Bismuth; Chi-Square Distribution; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leukocytes; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pumps; Recurrence | 1994 |
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1994 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Stomach Ulcer | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Metronidazole; Omeprazole | 1994 |
[Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative?].
Topics: Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1994 |
Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.
Topics: Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1993 |
One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Tetracycline | 1994 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colloids; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Tetracycline; Time Factors | 1996 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Remission Induction; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Duodenum; Female; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1995 |
Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Single-Blind Method; Tetracycline; Time Factors | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Double-Blind Method; Gastric Acid; Gastric Juice; Gastric Mucosa; Humans; Male; Metronidazole; Omeprazole; Penicillins; Saliva; Tissue Distribution | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1996 |
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Tetracycline | 1995 |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Urea | 1996 |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1996 |
4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Premedication; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors | 1996 |
Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Duodenal Ulcer; Female; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Tetracycline | 1996 |
One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline | 1995 |
Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Prospective Studies; Time Factors | 1996 |
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence | 1996 |
Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Recurrence; Serologic Tests; Tetracycline | 1996 |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance | 1996 |
One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1996 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Placebos; Precancerous Conditions; Stomach Neoplasms; Vitamins | 1996 |
Therapeutic options after failed Helicobacter pylori eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retreatment; Treatment Failure | 1996 |
Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Salicylates; Salicylic Acid | 1996 |
A liquid chromatography assay for the study of serum and gastric juice metronidazole concentrations in the treatment of Helicobacter pylori.
Topics: Antitrichomonal Agents; Chromatography, High Pressure Liquid; Drug Interactions; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1996 |
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tinidazole; Treatment Failure | 1996 |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antibodies, Bacterial; Azithromycin; Biomarkers; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pepsinogens | 1996 |
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Time Factors | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Biopsy; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Norway; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Ulcer | 1997 |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Time Factors | 1997 |
One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Diarrhea; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer Hemorrhage; Stomach Ulcer; Tetracycline | 1997 |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Single-Blind Method; Time Factors | 1997 |
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Oxytetracycline; Penicillins; Prospective Studies; Recurrence; Time Factors | 1997 |
Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Treatment Outcome | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1997 |
Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Neoplasms; Genes, Immunoglobulin; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
Topics: Adult; Anti-Ulcer Agents; Antitrichomonal Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Gastric Juice; Half-Life; Humans; Male; Metabolic Clearance Rate; Metronidazole; Omeprazole; Saliva | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Antineoplastic Agents, Alkylating; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Gastric Mucosa; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Sensitivity and Specificity; Treatment Outcome | 1997 |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; United States | 1997 |
Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life | 1997 |
The management of failed dual or triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Tetracycline; Treatment Failure | 1997 |
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Smoking; Tetracycline; Tetracyclines | 1997 |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides | 1997 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Safety; Taste Disorders; Treatment Outcome | 1996 |
Quadruple therapy: the golden bullet or a drug too far?
Topics: Antacids; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Patient Dropouts; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Tetracycline; Time Factors; Treatment Outcome | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1996 |
Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Bacterial Proteins; Breath Tests; Carbon Isotopes; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Urea; Urease | 1996 |
One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Taste Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 1997 |
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin; Stomach Ulcer | 1997 |
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole | 1997 |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Oxytetracycline; Prospective Studies | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Confidence Intervals; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Placebos; Stomach; Time Factors | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method | 1997 |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Prospective Studies; Smoking; Treatment Outcome | 1997 |
[Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Single-Blind Method | 1997 |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
[Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Time Factors | 1997 |
Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
Topics: Adult; Alginates; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Combinations; Drug Therapy, Combination; Esophagitis; Female; Gastrins; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Silicic Acid; Sodium Bicarbonate | 1998 |
Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Tetracycline; Western Australia | 1998 |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1998 |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Endoscopes; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Taste Disorders; Time Factors; Treatment Outcome | 1998 |
Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 1998 |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Failure | 1998 |
Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method; Treatment Outcome | 1997 |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pefloxacin; Proton Pump Inhibitors | 1998 |
Spiramycin as an alternative to amoxicillin treatment associated with lansoprazole/metronidazole for Helicobacter pylori infection in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Spiramycin | 1998 |
Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Antitrichomonal Agents; Biological Availability; Cross-Over Studies; Drug Interactions; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
Two-day 'weekend' lansoprazole-quadruple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 1998 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides | 1998 |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tetracycline; Treatment Outcome | 1998 |
Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Peptic Ulcer; Sulfoxides; Treatment Outcome | 1998 |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1998 |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors | 1998 |
A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Roxithromycin; Treatment Outcome | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1998 |
Chronic urticaria and Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Blood Donors; Breath Tests; Carbon Isotopes; Chronic Disease; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Remission Induction; Stomach; Urea; Urticaria | 1998 |
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1998 |
Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Tetracycline | 1998 |
Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole--an open pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Pilot Projects; Polypharmacy; Roxithromycin | 1998 |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Odds Ratio; Omeprazole; Penicillins; Prognosis; Prospective Studies; Time Factors | 1998 |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1999 |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Recurrence; Time Factors; Treatment Failure | 1999 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |
Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Single-Blind Method | 1999 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1999 |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Secondary Prevention; Sucralfate; Urea | 1999 |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens.
Topics: Adult; Amoxicillin; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pilot Projects | 1999 |
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Time Factors | 1999 |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach Ulcer; Time Factors | 1999 |
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia.
Topics: Adult; Aged; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1999 |
Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments.
Topics: Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Helicobacter pylori eradication: comparison of three treatment regimens in India.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Treatment Outcome | 1999 |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 1999 |
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pectins | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Single-Blind Method | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Stomach Ulcer | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
The OAC and OMC options.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Patient Dropouts; Random Allocation; Roxithromycin; Tinidazole; Turkey | 1999 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Benefit Analysis; Disease Management; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 1999 |
Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Outcome | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Middle Aged; Mouth; Omeprazole; Penicillins; Stomach | 1999 |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Contraindications; Drug Resistance, Microbial; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Resistance; Drug Therapy, Combination; Endoscopy; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Pylorus; Time Factors; Urea | 1999 |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome; Urea | 1999 |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Double-Blind Method; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Quality Control; Sulfoxides; Treatment Outcome; Urea | 2000 |
Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline | 2000 |
Furazolidone combination therapies for Helicobacter pylori infection in the United States.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Time Factors; United States | 2000 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea | 2000 |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asia, Southeastern; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method | 2000 |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 2000 |
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dental Plaque; DNA, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Mouth Mucosa; Omeprazole; Polymerase Chain Reaction; Saliva; Sensitivity and Specificity; Treatment Outcome; Urease | 2000 |
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bronchitis; Clarithromycin; Diarrhea; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides; Time Factors; Treatment Outcome | 2000 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Regression Analysis; Tetracycline; Treatment Outcome | 2000 |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 2000 |
Helicobacter pylori and its eradication in rosacea.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rosacea | 1999 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Treatment Failure; Vomiting | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2000 |
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Ranitidine; Tetracycline; Treatment Outcome | 2000 |
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Prospective Studies; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Pyloric Antrum; Sulfoxides | 2000 |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Primary Health Care; Prospective Studies; Stomach Ulcer; Tetracycline; Time Factors | 2000 |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2000 |
Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 2000 |
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Treatment Outcome | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 2000 |
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Quality of Life | 2000 |
A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2001 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2000 |
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy, Needle; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Probability; Prospective Studies; Rifabutin; Sulfoxides; Tetracycline; Treatment Failure | 2001 |
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea | 2001 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 2001 |
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2001 |
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Omeprazole; Organometallic Compounds; Secondary Prevention; Tetracycline | 2001 |
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome; Urea | 2001 |
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure | 2001 |
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probability; Ranitidine; Reference Values; Treatment Outcome | 2001 |
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
Topics: Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Probability; Reference Values; Treatment Outcome | 2001 |
Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence; Time Factors; Treatment Outcome | 2001 |
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Treatment Outcome | 2001 |
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Fish Oils; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 2001 |
Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Tetracycline; Treatment Outcome | 2001 |
Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Safety | 2001 |
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Tetracycline | 2001 |
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
Topics: Adolescent; Aged; Aged, 80 and over; Amoxicillin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Community Pharmacy Services; Community-Institutional Relations; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Education, Medical, Continuing; England; Family Practice; Female; Guideline Adherence; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Audit; Metronidazole; Omeprazole; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Program Evaluation; Proton Pump Inhibitors | 2001 |
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 2001 |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1999 |
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Probability; Tetracycline; Treatment Outcome | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Treatment Outcome; Urea | 2001 |
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Sickness Impact Profile | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Metronidazole; Omeprazole; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Taiwan | 2002 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2002 |
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Omeprazole; Tetracycline; Treatment Failure | 2002 |
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Canada; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Primary Health Care; Prospective Studies; Quality of Life; Treatment Outcome | 2002 |
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline | 2002 |
[Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2002 |
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pronase; Treatment Outcome | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Tetracycline | 2002 |
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides; Tetracycline; Treatment Failure; Treatment Outcome | 2002 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Urease | 2002 |
[Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction | 2002 |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 2002 |
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lansoprazole; Male; Metronidazole; Omeprazole; Severity of Illness Index; Stomach Diseases; Treatment Outcome; Vitamin E | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors; Treatment Outcome | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Wound Healing | 2002 |
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole | 2003 |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline | 2002 |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; North America; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides | 2003 |
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2003 |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Sweden; White People | 2003 |
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2003 |
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Gastric Mucosa; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salvage Therapy; Tetracyclines; Urea | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Tetracycline | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Severity of Illness Index; Treatment Outcome | 2003 |
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Failure | 2003 |
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome | 2003 |
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2004 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Internet; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Tetracycline | 2003 |
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; China; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach Ulcer; Tetracycline; Treatment Outcome; Turkey | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prevalence; Proton Pump Inhibitors; Proton Pumps; Statistics as Topic; Tetracycline; Treatment Outcome | 2003 |
Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Endoscopy, Gastrointestinal; Family Practice; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Outcome and Process Assessment, Health Care; Peptic Ulcer; Prospective Studies; Quality of Life; Referral and Consultation | 2004 |
Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Drug Interactions; Drug Synergism; Half-Life; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2004 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2004 |
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Salicylates; Tetracycline; Treatment Outcome | 2004 |
[Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment].
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence | 2004 |
The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 2004 |
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 2004 |
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.
Topics: Acute Disease; Amoxicillin; Antigens, CD; Coronary Disease; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; P-Selectin; Platelet Activation; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Recurrence; Tetraspanin 30 | 2004 |
Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Aminopyrine; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Sex Characteristics | 2005 |
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2005 |
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Drug Therapy, Combination; Duodenal Ulcer; Endothelin-1; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Omeprazole; Rabeprazole | 2005 |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors | 2005 |
Eradication rate of Helicobacter pylori in dyspeptic patients.
Topics: Analysis of Variance; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Drug Therapy, Combination; Dyspepsia; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Single-Blind Method; Tetracycline; Treatment Outcome; Urea | 2005 |
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Treatment Outcome | 2005 |
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Proton-Translocating ATPases; Pyloric Antrum; Rabeprazole; Retrospective Studies; Treatment Outcome | 2005 |
Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aminopyrine; Anti-Bacterial Agents; Anti-Infective Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole | 2005 |
Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2005 |
A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Stomach; Treatment Outcome | 2005 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer; Treatment Outcome | 2005 |
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prevalence; Prospective Studies; Risk Factors; Treatment Failure | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
[PPI plus bismuth-based quintuple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Minocycline; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Metronidazole; Middle Aged; Omeprazole; Tocopherols; Treatment Outcome | 2005 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Treatment Outcome | 2006 |
[Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Rural Population | 2006 |
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Rifabutin; Treatment Outcome | 2006 |
Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance | 2006 |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 2006 |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome | 2006 |
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.
Topics: Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Dopamine Agents; Double-Blind Method; Dyspepsia; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Metronidazole; Omeprazole; Peptic Ulcer; Sucrose; Tetracycline; Treatment Outcome | 2006 |
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps | 2006 |
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Rifabutin; Tetracycline; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2007 |
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Rifabutin; Tetracycline; Treatment Failure | 2008 |
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retreatment; Treatment Outcome | 2008 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analysis; Cross-Sectional Studies; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2008 |
[Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Omeprazole; Time Factors; Treatment Outcome | 2008 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Prevalence; Secondary Prevention | 2009 |
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Quinolines; Recurrence; Retreatment; Single-Blind Method; Tetracycline; Young Adult | 2009 |
The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Bismuth; Dietary Supplements; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Young Adult | 2009 |
A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; China; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Pilot Projects; Placebos; Rural Population; Tetracycline; Urea | 2010 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; Curcumin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Metronidazole; Middle Aged; Omeprazole | 2010 |
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, CD1; Clarithromycin; Complement Factor D; Drug Combinations; Female; Helicobacter; Helicobacter Infections; Immunocompromised Host; Male; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Omeprazole; Rodent Diseases | 2010 |
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2010 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tablets; Tetracycline; Young Adult | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Treatment Outcome | 2011 |
Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Omeprazole; Prospective Studies | 2012 |
Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Bismuth; Carotenoids; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lycopene; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2012 |
[A 10-day sequential therapy for eradication of Helicobacter pylori infection in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Time Factors; Treatment Outcome | 2012 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; China; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2013 |
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome; Urea; Young Adult | 2014 |
Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompromised Host; Iran; Kidney Transplantation; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2014 |
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2015 |
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Ireland; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2015 |
Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Phytotherapy; Plant Extracts; Treatment Outcome; Young Adult | 2015 |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2017 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline | 2018 |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Disease Eradication; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Rwanda; Treatment Failure | 2018 |
Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Random Allocation; Saccharomyces boulardii | 2019 |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
271 other study(ies) available for omeprazole and metronidazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Antiprotozoal activity of proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Benzimidazoles; Carbamates; Humans; In Vitro Techniques; Isoflavones; Ligands | 2021 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
In vitro activity of antifungal azoles against Helicobacter pylori.
Topics: Antifungal Agents; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1992 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tetracycline | 1995 |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1995 |
The susceptibility of Helicobacter pylori to the rifamycin, rifaximin.
Topics: Ampicillin; Drug Interactions; Drug Therapy, Combination; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Rifamycins; Rifaximin | 1995 |
90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1994 |
Helicobacter pylori eradication and reinfection.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts.
Topics: Anti-Bacterial Agents; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Tinidazole | 1994 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline | 1995 |
One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tinidazole | 1995 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1994 |
Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Omeprazole; Remission Induction; Stomach Neoplasms | 1995 |
Hitting H pylori for four.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 1995 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
[A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Norway; Omeprazole; Oxytetracycline; Peptic Ulcer | 1994 |
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Protein-Losing Enteropathies; Salicylates | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1993 |
Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 1993 |
One-day therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Treatment Outcome | 1993 |
Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum; T-Lymphocytes; Tetracycline | 1993 |
Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 1993 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer | 1995 |
Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Interactions; Erythromycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Sucralfate; Tetracycline | 1995 |
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Pyloric Stenosis; Tetracycline | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
Azithromycin for the cure of Helicobacter pylori infection.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Time Factors | 1996 |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Clarithromycin; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Penicillins; Urea; Urease | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Sex Factors; Smoking; Tetracycline; Time Factors; Wound Healing | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer; Tetracycline | 1996 |
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori.
Topics: Bismuth; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Salivary Gland Neoplasms | 1996 |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins | 1996 |
Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong.
Topics: Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Case-Control Studies; China; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum | 1996 |
Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial therapy.
Topics: Amoxicillin; Animals; Bacteriological Techniques; Cats; Cells, Cultured; Drug Therapy, Combination; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Omeprazole; Polymerase Chain Reaction; Saliva | 1996 |
Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Air; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Oxygen; Proton Pump Inhibitors | 1996 |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 1996 |
The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Primary Health Care; Prospective Studies; Serologic Tests | 1996 |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline | 1996 |
Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori.
Topics: Adult; Biological Transport, Active; Drug Therapy, Combination; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Metronidazole; Omeprazole | 1996 |
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyps; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1996 |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Electromyography; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Myoelectric Complex, Migrating; Omeprazole | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 1996 |
Endoscopic topical therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Topical; Amoxicillin; Antacids; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Instillation, Drug; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase | 1996 |
Eradication of helicobacter pylori among patients from a primary care practice.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Endoscopy; Evaluation Studies as Topic; Family Practice; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline; Treatment Outcome | 1996 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Tetracycline | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Roxithromycin; Treatment Outcome | 1996 |
Life-threatening interaction between clarithromycin and disopyramide.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disopyramide; Drug Interactions; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Ventricular Fibrillation | 1997 |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1997 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Metronidazole; Omeprazole; Pyloric Antrum; Time Factors | 1997 |
A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 1997 |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Buffers; Chromatography, High Pressure Liquid; Clarithromycin; Gastric Juice; Half-Life; Helicobacter; Helicobacter Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Metronidazole; Omeprazole; Penicillins; Solutions | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillins; Protein-Losing Enteropathies | 1997 |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 1997 |
Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1997 |
Gastric metaplasia and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Penicillins; Stomach; Treatment Outcome | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Superoxide Dismutase | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1997 |
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Risk Factors; Tetracyclines; Time Factors; Treatment Outcome; Wound Healing | 1997 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1997 |
Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1997 |
[Could Helicobacter pylori cause reactive arthro-osteitis?].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Digestive System; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Osteoarthritis; Sacroiliac Joint | 1997 |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Time Factors; Treatment Failure | 1997 |
One-day high-dose combined therapy of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Time Factors | 1997 |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Metronidazole; Omeprazole; Stomach | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins | 1997 |
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.
Topics: Ampicillin; Anti-Bacterial Agents; Clarithromycin; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Quebec | 1997 |
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum | 1998 |
Pragmatic eradication of H. pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1998 |
Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Tetracycline; Treatment Outcome | 1998 |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Metronidazole; Omeprazole; Peptic Ulcer; Time Factors | 1998 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Stomach Ulcer; Sulfoxides; Treatment Outcome | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Spiramycin | 1998 |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1998 |
The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Spain; Tetracycline | 1998 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; Enzyme Inhibitors; Evoked Potentials, Somatosensory; Female; Gastritis, Atrophic; Giardiasis; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxocobalamin; Malabsorption Syndromes; Metronidazole; Middle Aged; Neural Conduction; Omeprazole; Peripheral Nervous System Diseases; Remission Induction; Vitamin B 12 Deficiency | 1998 |
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Predictive Value of Tests; Treatment Outcome | 1998 |
Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline | 1997 |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole | 1998 |
A simple high performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluid.
Topics: Anti-Infective Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Gastric Juice; Humans; Metronidazole; Omeprazole; Sensitivity and Specificity | 1998 |
One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
[Triple treatment for the eradication of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence; Time Factors | 1998 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Humans; Malaysia; Metronidazole; Models, Economic; Omeprazole; Tetracycline | 1999 |
Understanding peptic ulcer disease pharmacotherapeutics.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1999 |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Toxins; Bacterial Vaccines; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli Proteins; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Metronidazole; Omeprazole; Organometallic Compounds; Recombinant Proteins; Salicylates; Saliva; Urease | 1999 |
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides | 1999 |
A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.
Topics: Adult; Aged; Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Roxithromycin | 1999 |
[Symptomatic improvement of patients with nonulcer dyspepsia after Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1999 |
Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Remission, Spontaneous; Treatment Outcome | 1999 |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Tetracycline Resistance; Treatment Outcome | 1999 |
Re-treatment after Helicobacter pylori eradication failure.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 1999 |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastrointestinal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence | 1999 |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colonic Neoplasms; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Omeprazole | 2000 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Omeprazole; Penicillins; Stomach Neoplasms | 2000 |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors | 2000 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole | 2000 |
Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 2000 |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute-Phase Reaction; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Breath Tests; Cholesterol, HDL; Cholesterol, LDL; Clarithromycin; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Triglycerides; Urea | 2000 |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Treatment Outcome; United States | 2000 |
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Stomach; Stomach Neoplasms | 2000 |
Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds | 2000 |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine | 2000 |
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Endoscopy, Gastrointestinal; Feces; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Lansoprazole; Male; Metronidazole; Omeprazole; Stomach; Urea | 2000 |
OAM for cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Penicillins | 2000 |
[The role of omeprazole in the eradication of Helicobacter pylori in patients with duodenal ulcers].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 2000 |
[Upgrading efficiency and safety of combined antihelicobacterial treatment of ulcer patients using modern clinicopharmacological approaches].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Treatment Outcome | 2000 |
Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B-Lymphocytes; Base Sequence; Biopsy; Clone Cells; Data Interpretation, Statistical; DNA, Complementary; DNA, Neoplasm; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Molecular Sequence Data; Omeprazole; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Time Factors | 2000 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 2000 |
[Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of a combination of omeprazole, clarithromycin and amoxycillin].
Topics: Anti-Ulcer Agents; Bismuth; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 2000 |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 2000 |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagellin; Genotype; Helicobacter Infections; Helicobacter pylori; Metronidazole; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Failure; Virulence | 2000 |
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Cohort Studies; Croatia; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sulfoxides | 2001 |
Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Stomach | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Stomach Diseases | 2001 |
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.
Topics: Amoxicillin; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Stability; Gastric Acidity Determination; Genotype; Helicobacter pylori; Hydrogen-Ion Concentration; Metronidazole; Mixed Function Oxygenases; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Immunoglobulin M; Metronidazole; Omeprazole; Time Factors | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Laparoscopy; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Postoperative Complications; Ranitidine; Recurrence; Stomach Ulcer; Tetracycline; Time Factors | 2001 |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Topics: Adult; Aged; Chi-Square Distribution; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Probability; Prospective Studies; Stomach Ulcer; Thailand; Treatment Outcome | 2001 |
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori.
Topics: Biopsy; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Gastritis; Humans; Metronidazole; Omeprazole; Stomach Ulcer | 2000 |
Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Rosacea; Sulfoxides | 2001 |
The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2001 |
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Benzimidazoles; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Duodenoscopy; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2001 |
The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Cimetidine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Feces; Glycyrrhiza; Glycyrrhizic Acid; Hydrolysis; Male; Metronidazole; Muscarinic Antagonists; Omeprazole; Paeonia; Peptic Ulcer; Phytotherapy; Rats; Rats, Wistar | 2001 |
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2002 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Occupational Diseases; Omeprazole; Prospective Studies; Treatment Outcome | 2002 |
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Enzyme Inhibitors; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Retrospective Studies; Tetracycline; Treatment Failure; Treatment Outcome | 2001 |
Resolution of collagenous colitis after treatment for Helicobacter pylori.
Topics: Aged; Biopsy, Needle; Clarithromycin; Colitis; Collagen; Diarrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2002 |
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Serologic Tests | 2002 |
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillin Resistance; Penicillins; Retrospective Studies | 2002 |
Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Synergism; Drug Therapy, Combination; Electron Transport; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Nizatidine; Omeprazole | 2002 |
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clarithromycin; Drug Therapy, Combination; Fluorescent Antibody Technique, Indirect; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Macrophages; Metronidazole; Omeprazole; Treatment Outcome | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Family; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm, Residual; Omeprazole | 2002 |
Quantification of Helicobacter pylori resistance in functional and organic dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2002 |
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Suture Techniques; Vagotomy, Proximal Gastric | 2002 |
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole | 2002 |
Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colony Count, Microbial; Helicobacter Infections; Helicobacter pylori; Mastic Resin; Metronidazole; Mice; Microbial Sensitivity Tests; Omeprazole; Resins, Plant; Stomach | 2003 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Mucus; Omeprazole; Severity of Illness Index | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
[Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Treatment Outcome | 2003 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Pyloric Stenosis; Ranitidine; Time Factors | 2003 |
Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 2003 |
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enterococcus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2003 |
Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enterococcus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2003 |
Asthma-like syndrome in a teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asthma; Benzimidazoles; Bronchi; Bronchodilator Agents; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Drug Therapy, Combination; Fluticasone; Forced Expiratory Flow Rates; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Immunoglobulin E; Lung Neoplasms; Male; Metronidazole; Omeprazole; Pantoprazole; Radioallergosorbent Test; Respiratory Sounds; Sulfoxides; Syndrome; Tomography, X-Ray Computed; Tuberculin Test; Vital Capacity | 2003 |
[Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter].
Topics: Adjuvants, Immunologic; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antiviral Agents; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Metronidazole; Omeprazole | 2003 |
[Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Treatment Outcome | 2003 |
Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Omeprazole; Ranitidine; Retrospective Studies; Treatment Outcome | 2003 |
Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: a pilot study.
Topics: Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Residues; Hair; Horses; Male; Metronidazole; Omeprazole; Pilot Projects; Procaine; Substance Abuse Detection; Sulfadiazine; Trimethoprim; Veterinary Drugs | 2004 |
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.
Topics: Adult; Age Factors; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Sex Factors; Time Factors; Treatment Outcome; United Kingdom | 2004 |
Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.
Topics: Achlorhydria; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2004 |
Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus.
Topics: Animals; Antitrichomonal Agents; Blotting, Western; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Iron Deficiencies; Kinetics; Metronidazole; Mice; Mice, Inbred BALB C; Omeprazole; Pyruvate Decarboxylase; Tritrichomonas foetus | 2004 |
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Treatment Outcome | 2004 |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Treatment Outcome | 2004 |
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Treatment Outcome | 2004 |
Effects of Helicobacter pylori eradication among adults with intellectual disability.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intellectual Disability; Male; Mental Disorders; Metronidazole; Omeprazole; Outcome Assessment, Health Care; Treatment Outcome | 2004 |
[Efficacy of 14 day OBMT therapy as a second-line treatment for Helicobacter pylori infection].
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retreatment; Tetracycline | 2004 |
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2004 |
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides | 2004 |
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retreatment; Time Factors | 2004 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
[The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
Topics: Absorption; Amoxicillin; Animals; Antacids; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Kidney; Male; Metronidazole; Omeprazole; Organometallic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley | 2005 |
Eradication of Helicobacter spp. from a rat breeding colony.
Topics: Amoxicillin; Animal Feed; Animals; Animals, Laboratory; Clarithromycin; DNA Primers; Electrophoresis, Agar Gel; Feces; Helicobacter; Helicobacter Infections; Metronidazole; Omeprazole; Polymerase Chain Reaction; Rats; RNA, Ribosomal, 16S; Rodent Diseases | 2005 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Omeprazole; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taiwan; Time Factors; Treatment Outcome | 2005 |
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunophenotyping; Immunoproliferative Small Intestinal Disease; Intestine, Small; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Mesentery; Metronidazole; Omeprazole; Pantoprazole; Retroperitoneal Space; Sulfoxides | 2005 |
How effective are quadruple therapies as first-line H. pylori eradication therapies?
Topics: Adult; Anti-Infective Agents; Australia; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Netherlands; Omeprazole; Tetracycline; Treatment Outcome | 2005 |
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Rifabutin; Sulfoxides; Treatment Outcome | 2006 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastrectomy; Gastric Mucosa; Gastric Stump; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Stomach Neoplasms | 2005 |
[Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenum; Esophagus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Stomach | 2006 |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Recurrence; Risk Factors; Tetracycline | 2006 |
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Perforation; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Time Factors | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Duodenal Ulcer; Duodenum; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach | 2006 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
Chest pain during triple therapy for duodenal ulcer.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chest Pain; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hiccup; Humans; Male; Mediastinal Emphysema; Metronidazole; Omeprazole; Radiography, Thoracic; Tomography, X-Ray Computed | 2007 |
Conservative management of esophageal perforation following obesity surgery.
Topics: Anti-Bacterial Agents; Ceftriaxone; Enteral Nutrition; Enzyme Inhibitors; Esophageal Perforation; Female; Gastroplasty; Humans; Intraoperative Complications; Laparoscopy; Metronidazole; Middle Aged; Obesity, Morbid; Omeprazole | 2006 |
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pyloric Antrum; Sensitivity and Specificity; Treatment Outcome; Urease | 2007 |
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].
Topics: Adolescent; Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prevalence; Sex Factors; Socioeconomic Factors; Time Factors | 2007 |
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2007 |
Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenitis; Duodenoscopy; Duodenum; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index | 2007 |
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteroides; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Feces; Female; Gram-Positive Cocci; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Nose; Omeprazole; Pharynx; Prospective Studies | 2007 |
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure | 2006 |
[Sequential therapy regimen for Helicobacter pylori infection in children].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Omeprazole; Prospective Studies; Time Factors | 2008 |
Chronic urticaria and Helicobacter pylori.
Topics: Adolescent; Adult; Amoxicillin; Case-Control Studies; Chronic Disease; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; India; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Urticaria; Young Adult | 2008 |
A search for Helicobacter pyloriin localized vulvodynia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Metronidazole; Omeprazole; Vulvar Diseases; Young Adult | 2008 |
Effects of helicobacter pylori eradication on chronic nonspecific pharyngeal symptoms.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Satisfaction; Pharyngeal Diseases; Probability; Prognosis; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Case-Control Studies; Chronic Disease; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Severity of Illness Index; Stomach; Urticaria | 2009 |
Pneumomediastinum, stomach wall and hepatic portal vein gas secondary to partial necrosis of the stomach wall.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Embolism, Air; Humans; Male; Mediastinal Emphysema; Metronidazole; Necrosis; Omeprazole; Portal Vein; Stomach; Stomach Diseases | 2009 |
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome | 2010 |
Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Cytomegalovirus Infections; Dietary Supplements; Ganciclovir; Humans; Iron, Dietary; Male; Metronidazole; Middle Aged; Omeprazole; Postoperative Complications; Pouchitis; Proctocolectomy, Restorative; Recurrence; Valganciclovir | 2010 |
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.
Topics: Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Feces; Gastrointestinal Tract; Humans; Metronidazole; Oligonucleotides; Omeprazole; Pharynx; Phylogeny; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 16S; Time Factors | 2010 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
Diagnostic exercise: chronic vomiting in a dog.
Topics: Animals; Antiprotozoal Agents; Biopsy; Cryptosporidiosis; Cryptosporidium; Diagnosis, Differential; DNA, Protozoan; Dog Diseases; Dogs; Foreign Bodies; Immunohistochemistry; Male; Metronidazole; Omeprazole; Polymerase Chain Reaction; RNA, Ribosomal, 18S; Stomach Diseases; Vomiting | 2010 |
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
Topics: Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Treatment Outcome | 2010 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Prognosis; Ranitidine; Smoking; Stomach; Time Factors | 2010 |
The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Male; Metronidazole; Omeprazole; Stomach; Treatment Outcome | 2011 |
Haematological side effect of Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Hematologic Diseases; Humans; Male; Metronidazole; Omeprazole | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pakistan; Prevalence; Statistics as Topic; Stomach Ulcer; Treatment Outcome; Young Adult | 2010 |
Quadruple or triple therapy to eradicate H pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tablets; Tetracycline | 2011 |
Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.
Topics: Anti-Bacterial Agents; Bismuth; Capsules; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 2011 |
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Omeprazole; Pronase | 2011 |
Warfarin.
Topics: Anti-Infective Agents; Anti-Ulcer Agents; Anticoagulants; Drug Interactions; Educational Measurement; Humans; Metronidazole; Omeprazole; Warfarin | 2011 |
Is quadruple therapy the new triple therapy for H pylori?
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2012 |
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Biopsy; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2012 |
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hispanic or Latino; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Tetracycline; Texas; Time Factors; Treatment Outcome; Urea | 2012 |
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Developing Countries; Drug Therapy, Combination; Educational Status; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Middle Aged; Morocco; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Recurrence; Urea; Urease; Young Adult | 2013 |
Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2013 |
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Tokyo; Young Adult | 2013 |
Helicobacter pylori and anemia with pregnancy.
Topics: Adult; Ampicillin; Anemia, Iron-Deficiency; Anti-Infective Agents; Drug Therapy, Combination; Female; Ferritins; Ferrous Compounds; Glycine; Glycine Agents; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Iron; Metronidazole; Omeprazole; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Proton Pump Inhibitors | 2014 |
Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Topics: Albendazole; Antiprotozoal Agents; Axenic Culture; Cysteine; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Escherichia coli; Gene Expression; Giardia lamblia; Humans; Metronidazole; Mutation; Nitro Compounds; Omeprazole; Parasitic Sensitivity Tests; Protozoan Proteins; Recombinant Proteins; Spectrometry, Fluorescence; Thiazoles; Triose-Phosphate Isomerase; Trophozoites | 2014 |
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rifabutin; Salvage Therapy; Spain; Tetracycline; Time Factors; Treatment Outcome | 2015 |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL10; Chemokine CXCL9; Clarithromycin; Gastric Mucosa; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice, Inbred C57BL; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 2015 |
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Carcinogenesis; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Goblet Cells; Helicobacter; Helicobacter Infections; Intestinal Neoplasms; Intestines; Male; Metronidazole; Mice, Inbred C57BL; Omeprazole; Verrucomicrobia | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.
Topics: Anti-Infective Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Tetracycline | 2016 |
Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2015 |
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2017 |
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera
Topics: Adult; Aged; Breath Tests; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Retrospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2018 |
Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; California; Causality; Clarithromycin; Cohort Studies; Comorbidity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Young Adult | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Omeprazole; Tinidazole | 2019 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comorbidity; Drug Therapy, Combination; Dyspepsia; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Spain | 2020 |
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Child; China; Clarithromycin; Cross-Sectional Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors | 2020 |
Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
Topics: Adolescent; Anti-Bacterial Agents; Bismuth; Child; Clarithromycin; Cross-Sectional Studies; Drug Hypersensitivity; Dysbiosis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors | 2020 |
Helicobacter pylori and antibiotic resistance in the pediatric population: an update from Vietnam.
Topics: Amoxicillin; Bismuth; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Probiotics; Proton Pump Inhibitors; Vietnam | 2020 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
HPLC Determination of Imidazoles with Variant Anti-Infective Activity in Their Dosage Forms and Human Plasma.
Topics: Albendazole; Anti-Infective Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Fenbendazole; Humans; Hydrogen-Ion Concentration; Imidazoles; Metronidazole; Omeprazole; Patient Safety; Reproducibility of Results; Solvents; Temperature; Ultraviolet Rays; United States; United States Food and Drug Administration | 2020 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult | 2021 |
RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin, and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Naproxen; Omeprazole; Research Design; Tinidazole | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |